Old Web
English
Sign In
Acemap
>
authorDetail
>
Natalie Miller
Natalie Miller
Fred Hutchinson Cancer Research Center
Toll-like receptor
TLR4
Pathology
Merkel cell carcinoma
Agonist
2
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pilot trial of intratumoral (IT) G100, a toll-like receptor-4 (TLR4) agonist, in patients (pts) with Merkel cell carcinoma (MCC): Final clinical results and immunologic effects on the tumor microenvironment (TME).
2016
Journal of Clinical Oncology
Shailender Bhatia
Natalie Miller
Hailing Lu
Dafina Ibrani
Michi Shinohara
David Byrd
Upendra Parvathaneni
Natalie Vandeven
Rima Kulikauskas
Jan ter Meulen
Frank J. Hsu
David M. Koelle
Paul Ngheim
Show All
Source
Cite
Save
Citations (6)
Pilot study of intratumoral G100, toll-like receptor-4 (TLR4) agonist, therapy in patients with Merkel cell carcinoma (MCC).
2015
Journal of Clinical Oncology
Shailender Bhatia
Dafina Ibrani
Natalie Vandeven
Natalie Miller
Michi Shinohara
David Byrd
Upendra Parvathaneni
Erica Shantha
Olga K. Afanasiev
Michael Donahue
David M. Koelle
Frank J. Hsu
Paul Nghiem
Show All
Source
Cite
Save
Citations (4)
1